Disase-specific survival | Metastasis-free survival | Recurrence-free survival | |||||
---|---|---|---|---|---|---|---|
Marker expression | Patients (n) | 5-Year survival (%) | P | 5-Year survival (%) | P | 5-Year survival (%) | P |
PDGF-A | |||||||
Low | 23 | 49 | 0.473 | 63 | 0.593 | 65 | 0.315 |
High | 39 | 63 | 54 | 73 | |||
Missing | 4 | ||||||
PDGF-B | |||||||
Low | 14 | 54 | 0.604 | 82 | 0.088 | 61 | 0.291 |
High | 48 | 59 | 51 | 73 | |||
Missing | 4 | ||||||
PDGF-C | |||||||
Low | 20 | 39 | 0.297 | 59 | 0.986 | 53 | 0.045 |
High | 41 | 65 | 56 | 76 | |||
Missing | 5 | ||||||
PDGF-D | |||||||
Low | 48 | 52 | 0.078 | 52 | 0.197 | 70 | 0.343 |
High | 15 | 80 | 73 | 59 | |||
Missing | 3 | ||||||
PDGFR-α | |||||||
Low | 41 | 56 | 0.672 | 61 | 0.527 | 71 | 0.761 |
High | 21 | 61 | 51 | 66 | |||
Missing | 4 | ||||||
PDGFR-β | |||||||
Low | 58 | 57 | 0.360 | 54 | 0.532 | 70 | 0.766 |
High | 4 | 75 | 75 | 75 | |||
Missing | 4 | ||||||
VEGF-A | |||||||
Low | 34 | 51 | 0.326 | 64 | 0.719 | 64 | 0.054 |
High | 29 | 68 | 53 | 79 | |||
Missing | 3 | ||||||
VEGF-C | |||||||
Low | 34 | 66 | 0.402 | 69 | 0.071 | 62 | 0.051 |
High | 29 | 50 | 45 | 84 | |||
Missing | 3 | ||||||
VEGF-D | |||||||
Low | 34 | 60 | 0.856 | 62 | 0.388 | 63 | 0.116 |
High | 30 | 55 | 51 | 78 | |||
Missing | 2 | ||||||
VEGFR-1 | |||||||
Low | 37 | 55 | 0.724 | 63 | 0.358 | 70 | 0.510 |
High | 25 | 63 | 49 | 71 | |||
Missing | 3 | ||||||
VEGFR-2 | |||||||
Low | 44 | 55 | 0.858 | 63 | 0.446 | 69 | 0.821 |
High | 19 | 67 | 48 | 75 | |||
Missing | 3 | ||||||
VEGFR-3 | |||||||
Low | 36 | 54 | 0.552 | 59 | 0.821 | 65 | 0.220 |
High | 25 | 61 | 52 | 76 | |||
Missing | 5 | ||||||
FGF2 | |||||||
Low | 39 | 56 | 0.805 | 51 | 0.214 | 74 | 0.748 |
High | 20 | 65 | 67 | 66 | |||
Missing | 7 | ||||||
FGFR-1 | |||||||
Low | 43 | 45 | 0.023 | 56 | 0.385 | 68 | 0.448 |
High | 20 | 89 | 63 | 78 | |||
Missing | 3 |